Thomas Fratacci - Biotech Acquisition CFO Treasurer
BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Insider
Thomas Fratacci is CFO Treasurer of Biotech Acquisition Co
Age | 45 |
Phone | 212 227 1905 |
Biotech Acquisition Management Efficiency
Biotech Acquisition's management efficiency ratios could be used to measure how well Biotech Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.Biotech Acquisition Co currently holds 153.35 K in liabilities with Debt to Equity (D/E) ratio of 3.48, implying the company greatly relies on financing operations through barrowing. Biotech Acquisition has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biotech Acquisition's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Niall Hogan | Integral Ad Science | N/A | |
R Esper | United Natural Foods | N/A | |
William LaFoy | Boston Omaha Corp | 63 | |
Tania Secor | Integral Ad Science | N/A | |
Anil Sukumaran | Integral Ad Science | N/A | |
Lisa Utzschneider | Integral Ad Science | 56 | |
Shayn Wallace | John B Sanfilippo | 52 | |
William Krueger | The Andersons | 58 | |
Hagit Shamir | BOS Better Online | N/A | |
John Kraus | The Andersons | N/A | |
Bradford Briner | Boston Omaha Corp | 43 | |
Oleg Bershadsky | Integral Ad Science | 42 | |
Mark Bushway | United Natural Foods | N/A | |
Noah Webster | Integral Ad Science | 51 | |
Brendan Keating | Boston Omaha Corp | 38 | |
Vishnu Srinivasan | Boston Omaha Corp | 41 | |
Steven McGhie | Boston Omaha Corp | 58 | |
John Clare | United Natural Foods | 53 | |
Helene Monat | Integral Ad Science | N/A | |
Lisa Nadler | Integral Ad Science | 62 | |
Robert Janecek | Integral Ad Science | N/A |
Management Performance
Return On Asset | -0.0085 |
Biotech Acquisition Leadership Team
Elected by the shareholders, the Biotech Acquisition's board of directors comprises two types of representatives: Biotech Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotech. The board's role is to monitor Biotech Acquisition's management team and ensure that shareholders' interests are well served. Biotech Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotech Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Shleifer, Chairman CEO | ||
Ivan Jarry, Chief Officer | ||
Albert MBA, Chief Director | ||
Thomas Fratacci, CFO Treasurer |
Biotech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotech Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.0085 | |||
Current Valuation | 290.09 M | |||
Shares Outstanding | 23 M | |||
Shares Owned By Institutions | 100.00 % | |||
Number Of Shares Shorted | 9.3 K | |||
Price To Earning | 29.21 X | |||
Price To Book | 1.33 X | |||
EBITDA | (6.86 M) | |||
Net Income | (6.86 M) | |||
Cash And Equivalents | 1.7 K |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |